References
- Murphy W M, Beckwith J B, Farrow G M. Tumours of the Kidney, Bladder, and Related Urinary Structures. AFIP Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC 1995; 92–136, 3rd Series, Fascicle 11
- Rendon R A, Stanietzky N, Panzarella T, et al. The natural history of small renal masses. J Urol 2000; 164: 1143–7
- Salama M E, Guru K, Stricker H, et al. pT1 substaging in renal cell carcinoma: Validation of the 2002 TNM staging modification of malignant renal epithelial tumors. J Urol 2005; 173: 1492–5
- Kovacs G, Akhtar M, Beckwith B J. The heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131–3
- Kovacs G. Molecular differential pathology of renal tumours. Histopathology 1993; 22: 1–8
- Lau W K, Cheville J C, Blute M L, Weaver A L, Zincke H. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002; 59: 532–7
- Remzi M, Ozsoy M, Klingler H C, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 2006; 176: 896–9
- Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop. Clin Nephrol 1985; 24: 107–19, No authors listed
- Mazal P R, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and PAX–2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod Pathol 2005; 18: 535–40
- Kim M K, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 2002; 10: 332–8
- Delahunt B, Eble J N. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997; 10: 537–44
- Yang X J, Tan M H, Kim H L. A molecular classification of papillary renal cell carcinoma. Cancer Res 2005; 65: 5628–37
- Sim S J, Ro J Y, Ordonez N G, Park Y W, Kee K H, Ayala A G. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Mod Pathol 1999; 12: 351–5
- Skinnider B F, Folpe A L, Hennigar R A, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005; 29: 747–54
- Tickoo S K, dePeralta-Venturina M N, Harik L R, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141–53
- Avery A K, Beckstead J, Renshaw A A, Corless C L. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24: 203–10
- McGregor D K, Khurana K K, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody ‘Renal Cell Carcinoma Marker’. Am J Surg Pathol 2001; 25: 1485–92